Skip to main content
. 2018 Mar 20;11(3):609–618. doi: 10.1016/j.tranon.2018.02.020

Figure 2.

Figure 2

FGFR3-TACC3 fusion-mediated oncogenic pathways in GBM. FGFR3-TACC3 protein can constitutively and automatically activate tyrosine kinase domain, which exerts oncogenic function weakly through PI3K/ATK, RAS/MAPK, and STAT3 signaling and may localize to mitotic spindle poles to trigger aneuploidy.